Trial Profile
A study investigating the effect and hematologic toxicity associated with vincristine sulfate liposome injection in patients with metastatic uveal melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Vincristine (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions
- 12 Dec 2015 New trial record